Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04483739
Title Isa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation (IsKia TRIAL) (IsKia)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors European Myeloma Network
Indications

multiple myeloma

Therapies

Carfilzomib + Dexamethasone + Lenalidomide

Carfilzomib + Dexamethasone + Isatuximab + Lenalidomide

Age Groups: adult | senior
Covered Countries ITA | ESP | DEU

Facility Status City State Zip Country Details
University Hospital Ostrava Recruiting Ostrava Czechia Details
Klinik und Poliklinik für Innere Medizin III Klinikum Rechts der Isars der TU München Not yet recruiting München Germany Details
Department of Clinical Therapeutics, University of Athens School of Medicine, Alexandra General Hospital of Athens Recruiting Athens Greece Details
ASST Spedali Civili di Brescia - Ematologia Not yet recruiting Brescia Italy Details
ErasmusMC, Rotterdam Not yet recruiting Rotterdam Netherlands Details
Oslo Myeloma Center Recruiting Oslo 0450 Norway Details
Clinica Universidad de Navarra Recruiting Madrid Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field